Watchlist Sponsored By :
- China: Low US Interest Rates Threaten Recovery
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- White House Plans to Freeze Spending to Cut Deficit
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Cities With the Most Home Price Reductions
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- This Year's Biggest Thanksgiving Leftover: Cash
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
MOST SHARED
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Today's Market Action
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- CNBC TRANSCRIPT: Warren Buffett & Bill Gates - Keeping America Great
- China's Role as Lender Alters Dynamics for United States
- Israel Going Green
- Inside Wal-Mart's Acai Berry Juice Maker
powered by digg
Merck, Schering To Develop Combo Pill With Lipitor
Topics:Pharmaceuticals | Medicine
Sectors:Health Care
Companies:Merck & Co Inc | Schering Plough Corp | Pfizer Inc
Text Size 
Merck [MRK
Loading...
()
] and Schering-Plough [SGP
Loading...
()
] said on Monday they were beginning development on a cholesterol-lowering product that would combine their Zetia drug with Pfizer's [PFE
Loading...
()
] Lipitor.
The development program is timed so the combination product could be available when the patent for Lipitor, known generically as atorvastatin, expires in the U.S. and
internationally, the companies said.
Lipitor, the world's largest-selling drug, is expected to face generic competition in the U.S. in 2010 or 2011.
Schering-Plough and Merck already have a joint venture to market Zetia and Vytorin, which combines Zetia with Merck's Zocor.
Click for related content
© 2009 CNBC.com
Print
Email
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
- A wealthy, distracted Texas driver crashed his million-dollar Bugatti Veyron sports car into a salt marsh, say police.
MORE FROM CNBC
TOPIC : Pharmaceuticals
SECTOR : Health Care
COMPANY : Merck & Co Inc
Data is a real-time snapshot *Data is delayed at least 15 minutes